Match Document Document Title
7479554 AAV5 nucleic acids  
The present invention provides an adeno-associated virus 5 (AAV5) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid...
7476391 Anti-bacterial vaccine compositions  
Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of...
7473554 Polynucleotides encoding novel Bt toxin receptors from lepidopteran insects  
The invention relates to Bt toxin resistance management. The invention particularly relates to the isolation and characterization of nucleic acid and polypeptides for a novel Bt toxin receptor. The...
7473762 Proteins and polypeptides from coagulaslase-negative staphylococci  
Proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis , including proteins designated SdrF, SdrG and SdrH, and their effective fragments such as their...
7473553 Polynucleotides encoding novel Bt toxin receptors from lepidopteran insects  
The invention relates to Bt toxin resistance management. The invention particularly relates to the isolation and characterization of nucleic acid and polypeptides for a novel Bt toxin receptor. The...
7468190 Reduction in the virulence of Mycobacterium tuberculosis and protection against tuberculosis by means of phoP gene inactivation  
The construction of a mutant in the phoP gene by means of homologous recombination from a clinically isolated Mycobacterium tuberculosis reduces the virulence thereof in mouse bone marrow...
7468185 Vaccine for periodontal disease  
The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein,...
7468256 Tools for detecting Moraxella catarrhalis  
The present invention provides compositions and methods useful for detecting Moraxella catarrhalis . The compositions are antibodies, proteins or nucleic acid sequences specific to Moraxella...
7465574 Recombinant RSV virus expression systems and vaccines  
The present invention relates to genetically engineered recombinant RS viruses and viral vectors which contain heterologous genes which for the use as vaccines. In accordance with the present...
7465568 Essential fungal polynucleotides, polypeptides, and methods of use  
The presnt invention provides essential fungal polynucleotides and their encoded polypeptides, homologues thereof and their uses. Additionally, the invention provides methods for the identification...
7462707 Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of Eimeria maxima and their uses  
The present invention provides an isolated nucleic acid comprising a nucleotide sequence encoding a 250 kDa polypeptide from Sporozoites/Merozoites of Eimeria maxima , or encoding a homolog of the...
7459153 Viral vectors for gene therapy  
Adenovirus types 11p and 4p show a higher binding affinity and infectivity than type 5 for endothelial and carcinoma cell lines. Adenovirus type 11p shows a stronger binding to cells for neural...
7459165 Polypeptides of Pseudomonas aeruginosa  
The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
7456272 Neurotoxins with enhanced target specificity  
Modified neurotoxins that contain protease cleavage sites susceptible uniquely to proteases present in certain tissues are described. The toxins can be selectively activated by proteases in muscle...
7453025 Reproductive ablation constructs  
The present invention relates to the regulation of reproductive development, particularly to the genetic ablation of reproductive tissues in angiosperm and gymnosperm species....
7449178 Attenuated gram negative bacteria  
Disclosed and claimed are a mutant of a gram negative bacterium, wherein said bacterium has at least one mutation in a nucleotide sequence which codes for a polypeptide having an identity which is...
7449310 Recombinant Fusobacterium necrophorum leukotoxin vaccine and preparation thereof  
The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein...
7449289 Methods for detection and identification of methicillin-resistant Staphylococcus aureus  
The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphyloccocus aureus (MRSA). It relates to the use of these DNA...
7446192 Gene participating in acetic acid tolerance, acetic acid bacteria bred using the gene, and process for producing vinegar with the use of the acetic acid bacteria  
The present invention is intended to provide novel genes participating in acetic acid tolerance of acetic acid bacteria, and a method of improving acetic acid tolerance of microorganisms,...
7445895 Methods, kits and assay system for detecting drug-resistant Mycobacterium tuberculosis  
The present invention relates to methods, kits and assay system for detecting drug-resistant Mycobacterium tuberculosis of suspected patient. The system of the present invention largely reduces...
7439034 Alginases, systems containing alginases and methods of cloning, purifying and/or utilizing alginases  
The present invention relates to cell wall degradative systems, in particular to systems containing enzymes that bind to and/or depolymerize cellulose. These systems have a number of applications.
7438912 S.agalactiae antigens I + II  
The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments...
7438916 Therapeutic target for protozoal diseases  
A novel Fasciclin Related Adhesive Protein (FRAP) from Plasmodium and related parasites is provided as a target for therapeutic intervention in diseases caused by the parasites. FRAP has been...
7432095 Formate dehydrogenase tolerant to halogen compounds and process for producing the same  
The invention provides a formate dehydrogenase having high specific activity, small Km values for formate and NAD, broad temperature and pH ranges of stability, broad temperature and pH ranges for...
7432350 Recombinant biotin carboxylase domains for identification of Acetyle CoA carboxylase inhibitors  
A peptide comprising an Acetyl CoA carboxylase (ACCase) having a deleted biotin binding domain, having a deleted carboxy transferase domain, and having a functional biotin carboxylase (BC) domain...
7432353 Fluorescent indicator proteins  
A protein biosensor having increased signal intensity to sugar concentration and the use thereof. A fluorescent indicator protein is described, in which fluorescent proteins of different emission...
7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof  
Provided are Moraxella catarrhalis BASB034 polypeptides and immunogenic fragments of BASB034 polypeptides. Preferably, the immunogenic fragments have at least 15 amino acids that match an aligned...
7432081 Ehrlichia disulfide bond formation proteins and uses thereof  
Novel genes encoding homologous immunoreactive thio-disulfide oxidoreductases, or disulfide bond formation (Dsb) proteins from Ehrlichia chaffeensis and Ehrlichia canis are disclosed. While the...
7432365 DNA molecules encoding beta clamp proteins of gram positive bacteria  
The present invention relates to beta protein-encoding genes from Gram positive bacterium. Expression systems and host cells containing these genes are also disclosed.
7429654 Cold-shock regulatory elements, constructs thereof, and method of use  
Regulatory elements of the 5′UTR of cold-shock inducible genes that prolong the expression of cold-shock inducible genes under conditions that elicit the cold-shock response in a bacterium,...
7427604 DNA encoding an antigenic protein of Eimeria apical membrane antigen 1 and use thereof  
This invention provides a novel DNA for preventing avian coccidiosis and use thereof. The novel DNA encodes an antigenic protein of Eimeria apical membrane antigen 1, and is used for DNA vaccine...
7422873 Mutant carotenoid ketolase  
CrtW carotenoid ketolases are provided useful for the production of astaxanthin. The ketolases genes of the present invention exhibit improved ketolase activity when converting cyclic hydroxylated...
7422754 Neisseria meningitidis compounds and anti-infection applications thereof  
The invention provides novel Neisseria meningitides (Nm) polypeptides and polynucleotides which cover the Nm genetic diversity, and which correspond to polypeptide of Nm outer membrane and/or...
7423137 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses  
The present invention provides the recombinant cloning and sequencing of two of the major Eimeria maxima gametocyte antigens having molecular weights of 56 and 82 kDa and the expression of these...
7419672 Genes and proteins, and their use  
According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or...
7419810 Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine  
L-Arginine is produced by culturing a coryneform bacterium in which an arginine repressor involved in L-arginine biosynthesis is deleted by disrupting a gene coding for the repressor, and which has...
7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof  
The invention provides BASB006 polypeptides and polynucleotides encoding BASB006 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic,...
7417138 PNA chip for determining genotypes of mycobacterial species using plastic substrate coated with epoxy group-containing polymer and method of determining genotypes of mycobacterial species using the PNA chip  
Provided are a PNA chip for determining the genotypes of mycobacterial species in which probe PNAs having DNA sequences of SEQ ID NOs: 5-28 are immobilized on a plastic substrate coated with an...
7417135 Plasmidic gene, ways of acquiring this gene, the amylolytic enzyme it encodes and its application  
The object of the invention is a novel plasmidic gene encoding an amylolytic enzyme which after introduction into a microbial strain, favorably bacterial, especially Lactococcus lactis , enables...
7410648 Polypeptides of Moraxella (Branhamella) catarrhalis  
The present invention relates to polypeptides, more particularly polypeptides of Moraxella ( Branhamella ) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (...
7410645 Moraxella (Branhamella) catarrhalis antigens  
The present invention relates to polypeptides of Moraxella ( Branhamella ) catarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes. 1 ATGGACACTG ACATGAAACA...
7410647 Antigenic polypeptides  
A method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to...
7408053 Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby  
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome,...
7407758 HCV variants  
HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive...
7407664 Peptide vaccines against group A streptococci  
This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of...
7399476 Nucleic acid free ghost preparations  
The invention relates to preparations of bacterial ghosts which are substantially free of living bacterial cells and/or nucleic acids and their use in pharmaceutical preparations.
7399623 Modified forms of pullulanase  
The present invention relates to modified pullulanases useful in the starch industry. The present invention provides methods for producing the modified pullulanase, enzymatic compositions...
7396536 Parasitic helminth cuticlin proteins and uses thereof  
The present invention relates to: parasitic helminth cuticlin proteins; parasitic helminth cuticlin nucleic acid molecules, including those that encode such cuticlin proteins; antibodies raised...
7390639 Staphylococcal nuclease fusion proteins for the production of recombinant peptides  
Peptides are produced as fusions with a suitable carrier protein. The carrier protein disclosed herein are adapted from the N-terminal domain of staphylococcus nuclease. This novel carrier...
7390892 Nucleic acids encoding novel cyclic GMP dependent protein kinases from Elmeria maxima  
The present invention relates to novel protozoal cyclic GMP dependent protein kinases and genes encoding same that have been isolated from Eimeria maxima and Plasmodium falciparum . Nucleic acid...